The Gut–GLP-1 Axis: How a Diverse Microbiome and Prebiotic Fiber Support Your Appetite Hormones
Your gut already makes GLP-1 — the appetite hormone behind today's headlines. Here's what peer-reviewed research says about how your microbiome and the fiber that feeds it support its natural production.
Glucagon-like peptide-1 (GLP-1) is having a cultural moment. It's the hormone that medications like semaglutide and tirzepatide were designed to mimic — and it's the reason "nature's Ozempic" has become a search-engine obsession. But long before any injectable existed, your own gut was producing GLP-1 every time you ate.[1][2]
GLP-1 is released by specialized enteroendocrine cells — called L-cells — that line the lower small intestine and colon. When these cells sense nutrients and, crucially, the metabolites produced by your gut bacteria, they release GLP-1 into circulation, where it helps signal fullness, slows the rate at which the stomach empties, and supports glucose-dependent insulin release.[1][3] In other words, the gut is not a passive tube. It's an endocrine organ — and the community of microbes living inside it has a remarkable amount of influence over the appetite signals it sends.[4]
This guide unpacks the gut–GLP-1 axis: how a diverse microbiome and the prebiotic fiber that feeds it are connected to your body's natural GLP-1 production, what the peer-reviewed evidence actually shows about fiber, short-chain fatty acids, foods, and specific probiotic species, and how to build an everyday routine that supports the gut environment where this hormone is made.
Already taking a GLP-1 medication?
This article is about supporting your body's own GLP-1 through gut health and nutrition — the upstream, food-and-microbiome side of the story. If you're taking a prescription GLP-1 receptor agonist and want guidance on gut comfort, fiber, and pairing probiotics with your medication, head to our companion guide on probiotics and GLP-1 medications like Ozempic instead. Nothing here is a substitute for prescribed treatment or medical advice.
Key Takeaways
- Your gut is the source of GLP-1. Enteroendocrine L-cells in the lower gut release GLP-1 in response to nutrients and microbial metabolites, influencing satiety, gastric emptying, and glucose-dependent insulin secretion.[1][3]
- Short-chain fatty acids are the key messengers. When gut bacteria ferment fiber, they produce butyrate, propionate, and acetate — which stimulate GLP-1 release from L-cells through the receptors FFAR2 (GPR43) and FFAR3 (GPR41).[5][6]
- Prebiotic fiber raises GLP-1 in human studies. Two weeks of the fermentable fiber oligofructose increased plasma GLP-1 and PYY, improved satiety, and reduced energy intake in healthy adults.[10]
- Delivering fermentable fiber to the colon changes appetite signaling. An inulin-propionate ester raised postprandial GLP-1 and PYY and reduced food intake in an overweight-adult randomized controlled trial.[12]
- Whole foods matter too. Fiber-rich foods, higher-protein meals, and fermented foods are each linked in research to greater GLP-1/PYY responses or a more diverse microbiome.[15][16][18]
- Specific probiotic species have been studied for GLP-1 and metabolic support. A multi-strain probiotic increased butyrate-induced GLP-1 in a landmark study, and species including Lactobacillus reuteri, Bifidobacterium breve, and Lactobacillus gasseri have been examined in human trials.[19][20][21]
- Diversity and consistency beat gimmicks. A varied microbiome fed by diverse prebiotics — not a single "magic" strain or an enormous CFU number — is what the research points toward for metabolic health.[24]
What GLP-1 Is — and Why Your Gut Is the Source
GLP-1 is an incretin hormone: a gut-derived signal that helps coordinate what happens after you eat. It's produced from a larger precursor protein (proglucagon) inside enteroendocrine L-cells, which are most concentrated in the distal small intestine and colon. When those cells detect incoming nutrients — and the byproducts of bacterial fermentation — they secrete GLP-1 into the bloodstream and also activate nearby sensory nerves.[1][3]
Once released, GLP-1 does several well-characterized things. It enhances glucose-dependent insulin secretion (meaning it prompts insulin release primarily when blood sugar is elevated), slows gastric emptying so a meal leaves the stomach more gradually, and acts on appetite centers in the brain to promote a feeling of fullness.[1][2] Native GLP-1 is broken down within minutes by an enzyme called DPP-4, which is precisely why pharmaceutical GLP-1 receptor agonists were engineered to resist that breakdown and last far longer.[2]
The takeaway for anyone interested in gut health is simple but powerful: because L-cells respond to signals arriving from the gut lumen, the environment inside your intestine — including the composition and activity of your microbiome — is directly upstream of how much GLP-1 gets made.[3][4] To understand that environment, it helps to start with what the gut microbiome actually is and how it shapes the systems it touches.
The Gut–GLP-1 Axis Explained
The "gut–GLP-1 axis" describes the two-way conversation between your microbial community and the hormone-producing cells of your intestine. Research over the last decade has shown that the gut microbiota helps shape L-cell biology and GLP-1 output — not just through the food you eat, but through the metabolites your bacteria create as they digest it.[4][5]
Germ-free and antibiotic studies first hinted at this: when the microbiome is altered, so is GLP-1 signaling and L-cell density. Reviews of microbial regulation of GLP-1 now describe several routes of influence — microbial fermentation products (short-chain fatty acids), bile acid transformation, and the general integrity of the gut barrier — all converging on the enteroendocrine cells that make GLP-1.[4][5] The relationship even appears bidirectional: emerging reviews note that GLP-1 signaling and the microbiome each influence the other.[25]
The Gut–Brain Piece of the Puzzle
GLP-1's appetite effects aren't only hormonal. A great deal of GLP-1 signaling happens through the nervous system — L-cells activate sensory neurons in the gut wall, and GLP-1 receptors in the brain govern satiety.[25] This is the same broader gut–brain axis that connects your digestive tract to mood and appetite, which is why the state of your gut can influence how satisfied you feel after a meal — not just how you digest it.
What makes this practical is that the microbiome is modifiable. Unlike your genetics, the makeup and activity of your gut bacteria shift in response to what you feed them — which is where fiber, and the short-chain fatty acids it becomes, take center stage.
SCFAs: The Link Between Fiber and GLP-1
If there's a single mechanism at the heart of the gut–GLP-1 axis, it's the short-chain fatty acid (SCFA) pathway. When beneficial bacteria ferment fermentable fiber in the colon, they produce three principal SCFAs — butyrate, propionate, and acetate. These aren't just waste products; they're signaling molecules.[5]
SCFAs bind to two specific receptors on the surface of L-cells: FFAR2 (also called GPR43) and FFAR3 (GPR41). Landmark mechanistic work showed that SCFAs trigger GLP-1 secretion through FFAR2, and that mice lacking this receptor have blunted SCFA-driven GLP-1 release and impaired glucose tolerance.[6] Propionate specifically has been shown to stimulate GLP-1 and PYY (another satiety hormone) release via FFAR2 in rodent and human colonic tissue.[7] In isolated perfused colon, butyrate and propionate dose-dependently stimulated GLP-1 secretion,[8] and studies in human enteroendocrine cells confirmed that SCFAs drive gut-hormone production in human (not just rodent) tissue.[9]
This is the elegant part: the fiber itself doesn't raise GLP-1 directly. The bacteria do, by converting fiber into SCFAs. That means the quality and diversity of your microbiome — how well it's equipped to ferment a range of fibers — is just as important as how much fiber you eat. For a deeper look at these metabolites and how to nurture their production, see our guide on how to increase butyrate and short-chain fatty acids naturally.
Prebiotic Fiber and Natural GLP-1 Support
Prebiotics are fibers and compounds that selectively feed beneficial gut bacteria. Among the most-studied for the gut–GLP-1 connection are the inulin-type fructans — including inulin and oligofructose — which are highly fermentable and reliably boost SCFA production.[10]
The human evidence here is unusually clean. In a controlled study, healthy adults who took 16 grams per day of oligofructose for two weeks showed increased colonic fermentation, higher plasma GLP-1 and PYY, lower post-meal glucose, reduced hunger ratings, and a measurable drop in total energy intake.[10] An earlier pilot from the same research group found oligofructose promoted satiety and reduced energy intake,[11] and a one-year trial of increased fermentable wheat fiber raised GLP-1 in adults with elevated insulin.[13]
Perhaps the most striking demonstration used an inulin-propionate ester — a molecule designed to deliver propionate straight to the colon. In an overweight-adult randomized controlled trial, this raised postprandial GLP-1 and PYY and reduced food intake acutely; over 24 weeks it significantly reduced the proportion of participants who gained weight.[12] A systematic review of prebiotic randomized controlled trials and a 2026 scoping review of dietary fibers both concluded that fermentable fibers can raise endogenous GLP-1 and satiety, while noting that effect sizes vary and depend on the fiber type and dose.[14][15]
| Prebiotic Studied | What the Research Observed | Study Type |
|---|---|---|
| Oligofructose (inulin-type) | Higher plasma GLP-1 & PYY, improved satiety, reduced energy intake[10] | Human trial |
| Inulin-propionate ester | Raised postprandial GLP-1/PYY; reduced weight gain over 24 weeks[12] | Human RCT |
| Fermentable wheat fiber | Increased fasting and 24-hour GLP-1 over one year[13] | Human RCT |
| Inulin-type fructans (pooled) | Consistent increases in satiety hormones including GLP-1[14] | Systematic review |
Feeding the Bacteria That Do the Work
Because SCFA production depends on feeding a diverse microbiome a variety of fermentable fibers, a synbiotic approach — beneficial bacteria plus the prebiotics that nourish them — is a sensible everyday strategy. MicroBiome Restore pairs its probiotic strains with an organic prebiotic complex built around Jerusalem artichoke — one of nature's richest inulin sources — alongside acacia fiber, a gentle prebiotic well-tolerated by sensitive guts, plus maitake mushroom, fig fruit, and sea vegetables. It's a diverse prebiotic matrix designed to support fermentation across the length of the colon. Want the full picture on prebiotic foods? See our roundup of the best prebiotics to boost your gut bacteria.
Foods That Support Natural GLP-1
You don't need a supplement to start supporting the gut–GLP-1 axis — the foundation is what's on your plate. Three food categories have the most research behind them.
Fiber-Rich Whole Foods
Fermentable fiber is the raw material for SCFA production, so fiber-rich foods are the cornerstone. Legumes, oats and barley (rich in beta-glucan), onions, garlic, leeks, asparagus, slightly-green bananas, and inulin-rich vegetables like Jerusalem artichoke all deliver fermentable fibers. The 2026 scoping review of dietary fibers concluded that fermentable fibers can increase endogenous GLP-1 and satiety, reinforcing a food-first approach.[15] Our guide to natural sources of prebiotics breaks down where to find them.
Protein at Meals
Dietary protein is a potent stimulus for gut-hormone release. In a crossover trial, a higher-protein meal produced significantly greater postprandial GLP-1 and PYY responses and higher satiety than higher-carbohydrate or higher-fat meals.[16] A mechanistic review details how protein (via amino-acid and peptide sensing) and calcium co-stimulate L-cell GLP-1 secretion.[17] Pairing protein with fiber at each meal is a practical, evidence-aligned habit.
Fermented Foods
Fermented foods support the microbial diversity that underpins SCFA capacity. A Stanford randomized controlled trial found that a 10-week high-fermented-food diet increased gut microbial diversity and lowered inflammatory markers in healthy adults.[18] Yogurt, kefir, sauerkraut, kimchi, and miso are easy additions — and a useful complement to a probiotic routine.
"Foods That Work Like Ozempic"? A Reality Check
You'll see fiber-and-protein foods marketed as "nature's Ozempic." Here's the honest framing: certain foods and fibers can modestly support your body's own GLP-1 through the mechanisms above, but no food or supplement replicates the magnitude or duration of a prescription GLP-1 receptor agonist. The value of a food-first, microbiome-friendly approach is that it's sustainable and supports overall gut health — not that it's a drug substitute. For the appetite-and-cravings angle, see our look at whether probiotics and prebiotics can curb sugar cravings.
Support Your Gut From the Inside Out
MicroBiome Restore brings together 26 research-backed probiotic strains and 9 organic prebiotics — a synbiotic built to nourish a diverse, well-fed microbiome as part of your daily routine. Delivered in a filler-free pullulan capsule, with no microcrystalline cellulose, magnesium stearate, or titanium dioxide.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Probiotic Species Studied for GLP-1 and Metabolic Support
Probiotic effects are strain-specific, and the research on GLP-1 is still developing. But several species have been examined in laboratory, animal, and human studies for their relationship to GLP-1, SCFA production, or metabolic markers. The species highlighted below are those with published evidence in this area.
Multi-Strain Formulations and Butyrate-Induced GLP-1
The cornerstone study here used a well-known multi-strain probiotic that combines Bifidobacterium (breve, longum, infantis), Lactobacillus (acidophilus, plantarum, paracasei, bulgaricus), and Streptococcus thermophilus. In mice, this formulation increased fecal butyrate, which in turn stimulated GLP-1 release from L-cells, reducing food intake and improving glucose tolerance and insulin sensitivity.[19] It's a clear illustration of how a diverse consortium of species — rather than one strain in isolation — can support the butyrate-to-GLP-1 pathway.
Lactobacillus reuteri
Lactobacillus reuteri is one of the few species with a direct human GLP-1 result. In a proof-of-concept trial, four weeks of L. reuteri supplementation increased glucose-stimulated GLP-1 secretion by 76%, along with improvements in insulin secretion, in glucose-tolerant adults.[20] Explore this species further in our overview of Lactobacillus reuteri benefits.
Bifidobacterium breve and B. longum
A 2025 randomized, double-blind, placebo-controlled trial reported that a Bifidobacterium breve strain significantly raised GLP-1 and fecal butyrate while improving insulin resistance in adults with obesity.[21] And Bifidobacterium longum is a classic example of cross-feeding: it releases acetate and sugars that butyrate-producing colon bacteria then convert into butyrate — the very SCFA that signals L-cells.[23] More on this genus in our guides to Bifidobacterium lactis benefits and what happens when Bifidobacterium runs low.
Lactobacillus gasseri
Lactobacillus gasseri has been studied for body composition rather than GLP-1 directly. In a randomized controlled trial, a specific L. gasseri strain was associated with reductions in visceral fat over 12 weeks, with effects that faded after supplementation stopped.[22] Read more in our feature on Lactobacillus gasseri.
| Species | Area Studied | Key Evidence |
|---|---|---|
| Multi-strain consortium | Butyrate-induced GLP-1 | Increased butyrate & GLP-1, improved glucose tolerance (animal)[19] |
| L. reuteri | Direct GLP-1 secretion | +76% glucose-stimulated GLP-1 in humans[20] |
| B. breve | GLP-1 & SCFA | Raised GLP-1 & fecal butyrate in a placebo-controlled RCT[21] |
| B. longum | SCFA cross-feeding | Feeds butyrate-producing bacteria via acetate[23] |
| L. gasseri | Body composition | Reduced visceral fat in a human RCT[22] |
Please Note: MicroBiome Restore Is Not a GLP-1 Medication or Weight-Loss Product
The research summarized above describes individual fibers, foods, and probiotic strains studied in laboratory, animal, and clinical settings — it does not describe outcomes for this or any specific product, and effect sizes in these studies are generally modest. MicroBiome Restore is a general microbiome-support supplement. It is not a GLP-1 receptor agonist, a weight-loss drug, or a substitute for any prescribed medication, and it is not intended to treat obesity, diabetes, or any other condition. If you're considering options for weight or metabolic health, talk with your healthcare provider.
Microbiome Diversity, Multi-Strain Synergy, and CFU
One theme runs through nearly all of this research: diversity. A more varied microbial community carries a broader set of fiber-fermenting and SCFA-producing capabilities, and reduced diversity is repeatedly linked to metabolic dysfunction. A top-tier review of gut microbiota in metabolic health describes how community composition and microbial metabolites — SCFAs among them — mediate the relationship between the microbiome and host metabolism.[24]
This is why multi-strain, multi-genus formulations make biological sense. Different species occupy different niches along the gut, ferment different substrates, and cross-feed one another — Bifidobacterium releasing acetate that butyrate-producers use, for example.[23] A community works in ways a single strain can't. Our comparison of single-strain vs. multi-strain probiotics and our overview of the top 10 probiotic strains for gut health both dig into why diversity matters.
Why Chasing a Huge CFU Number Misses the Point
It's tempting to shop for the highest colony-forming-unit (CFU) count on the shelf, but the studies above used a wide range of doses, and strain diversity plus prebiotic support often matter more than a raw CFU figure. A thoughtfully formulated multi-strain synbiotic delivering 15 billion CFU across 26 strains — paired with diverse organic prebiotics to actually feed them — reflects the "quality and diversity over sheer quantity" principle better than a single-strain product boasting 100 billion CFU. For more context, see our guide to prebiotics, probiotics, and synbiotics.
Fermented foods reinforce this too: the Stanford trial showed they can raise diversity in a way a single fiber sometimes doesn't over the same window.[18] The practical goal isn't one hero strain — it's a resilient, well-fed ecosystem.
Building a Gut-Friendly, GLP-1-Supportive Routine
Supporting the gut–GLP-1 axis is less about any single product and more about a consistent set of habits that build a diverse, well-fed microbiome. Here's what the evidence points toward.
Eat a Range of Fermentable Fibers
Variety is the operative word. Different bacteria ferment different fibers, so rotating inulin-rich vegetables, legumes, oats, and other prebiotic foods gives your microbiome more to work with than relying on one source. Increase fiber gradually to let your gut adapt.
Prioritize Protein and Fermented Foods
Anchor meals with protein for its gut-hormone effect,[16] and work fermented foods into your week to support diversity.[18]
Consider a Diverse Synbiotic
If you use a supplement, favor a multi-strain formula paired with real prebiotics, with strain-level transparency on the label. Learning to read probiotic labels to spot hidden fillers is one of the highest-leverage skills in supplement selection, and many people prefer filler-free probiotics without unnecessary additives.
Mind the Delivery
Probiotics have to survive stomach acid to reach the colon where L-cells are concentrated. Pullulan capsules — made from fermented tapioca — offer delayed-release protection without synthetic coatings and act as a mild prebiotic themselves.
Give It Time and Stay Consistent
Microbiome shifts and fermentation adaptation build over weeks, not hours — the one-year fiber trial showed GLP-1 responses can strengthen with sustained intake.[13] Consistency beats intensity.
A Note on Expectations and Medical Care
Supporting your body's natural GLP-1 through gut health is a wellness strategy, not a medical treatment. The effects seen in nutrition and probiotic studies are real but generally modest, and they are not equivalent to prescription therapy. If you're managing diabetes, obesity, or another condition — or considering GLP-1 medication — work with a qualified healthcare provider. Introduce new fibers or probiotics gradually, and check with your provider first if you're pregnant, immunocompromised, or seriously ill.
Frequently Asked Questions
How can I increase my GLP-1 naturally?
The evidence-aligned approach is to support the gut environment where GLP-1 is made: eat a variety of fermentable fibers to feed SCFA-producing bacteria, include protein at meals (which stimulates gut-hormone release), add fermented foods for microbial diversity, and stay consistent over weeks. Fermentable fibers like oligofructose have raised GLP-1 and satiety in human studies.[10][15] These effects are modest compared with medication, but they support overall gut and metabolic health.
What foods "work like Ozempic"?
No food replicates a prescription GLP-1 medication — that framing oversells the science. That said, fiber-rich foods (legumes, oats, onions, Jerusalem artichoke), higher-protein meals, and fermented foods can each modestly support your body's own GLP-1 and satiety signaling through the microbiome and L-cell pathways described above.[15][16] Think "supportive habit," not "drug substitute."
What is the "lazy GLP-1 diet"?
It's a social-media shorthand — not a medical protocol — for a low-effort eating pattern that front-loads fiber and protein and leans on fermented and whole foods to support natural satiety signaling. The individual components (more fermentable fiber, more protein, more microbial diversity) are consistent with the peer-reviewed research on GLP-1 and appetite hormones,[15][16] even though the catchy name isn't a scientific term.
Does prebiotic fiber really raise GLP-1, or is that marketing?
There's genuine human evidence. Controlled studies of fermentable fibers like oligofructose and an inulin-propionate ester have shown increases in plasma GLP-1 and PYY alongside improved satiety.[10][12] Reviews caution that the size of the effect depends on the fiber type, dose, and individual microbiome, so it's real but not a megadose miracle.[15]
Do I need a probiotic, or can I get everything from food?
Food first is a reasonable philosophy — fiber-rich and fermented foods do a lot of the work. A multi-strain synbiotic can be a convenient way to add strain diversity and pair bacteria with prebiotics, especially if your diet is inconsistent. The best choice is the one you'll take consistently, since microbiome effects accumulate over time.[13]
How long before gut-focused changes make a difference?
Some fermentation effects begin within days, but meaningful shifts in microbiome composition and SCFA output typically take a few weeks of consistent fiber intake, and GLP-1 responses can continue to strengthen over months.[13] Patience and consistency matter more than any single dose.
The Bigger Picture: Your Microbiome and Your Appetite Hormones
The story of GLP-1 didn't start with a prescription pad. It started in your gut — with enteroendocrine L-cells listening to the metabolites your bacteria produce every time you feed them fiber. That's the heart of the gut–GLP-1 axis: fermentable fiber becomes short-chain fatty acids, SCFAs signal through FFAR2 and FFAR3, and your body's own appetite and glucose hormones respond.[6][10]
What the research consistently rewards is a diverse, well-fed microbiome: a variety of fermentable fibers, protein and fermented foods at the table, strain diversity over single-strain gimmicks, and consistency over intensity.[18][24] None of it is a shortcut or a substitute for medical care — but it's a foundation for gut health that supports the systems your body already has. To see how a filler-free, 26-strain synbiotic was built around these principles, explore our complete guide to MicroBiome Restore.
26 Research-Backed Strains. 9 Organic Prebiotics. Zero Fillers.
MicroBiome Restore is formulated to nourish a diverse, balanced microbiome as part of your everyday routine — pairing 15 billion CFU across 26 strains with organic prebiotics like Jerusalem artichoke inulin, acacia, and maitake. Delivered in pullulan capsules with no microcrystalline cellulose, magnesium stearate, or titanium dioxide.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. MicroBiome Restore is a general microbiome-support supplement and is not a GLP-1 medication, weight-loss product, or a substitute for prescribed treatment.
References
- Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., … Tschöp, M. H. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010
- Drucker, D. J. (2018). Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism, 27(4), 740–756. https://doi.org/10.1016/j.cmet.2018.03.001
- Gribble, F. M., & Reimann, F. (2019). Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nature Reviews Endocrinology, 15(4), 226–237. https://doi.org/10.1038/s41574-019-0168-8
- Greiner, T. U., & Bäckhed, F. (2016). Microbial regulation of GLP-1 and L-cell biology. Molecular Metabolism, 5(9), 753–758. https://doi.org/10.1016/j.molmet.2016.05.012
- Everard, A., & Cani, P. D. (2014). Gut microbiota and GLP-1. Reviews in Endocrine and Metabolic Disorders, 15(3), 189–196. https://doi.org/10.1007/s11154-014-9288-6
- Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., … Gribble, F. M. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61(2), 364–371. https://doi.org/10.2337/db11-1019
- Psichas, A., Sleeth, M. L., Murphy, K. G., Brooks, L., Bewick, G. A., Hanyaloglu, A. C., … Frost, G. (2015). The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. International Journal of Obesity, 39(3), 424–429. https://doi.org/10.1038/ijo.2014.153
- Christiansen, C. B., Gabe, M. B. N., Svendsen, B., Dragsted, L. O., Rosenkilde, M. M., & Holst, J. J. (2018). The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. American Journal of Physiology-Gastrointestinal and Liver Physiology, 315(1), G53–G65. https://doi.org/10.1152/ajpgi.00346.2017
- Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Doré, J., Gribble, F. M., Reimann, F., & Blottière, H. M. (2018). SCFAs strongly stimulate PYY production in human enteroendocrine cells. Scientific Reports, 8, 74. https://doi.org/10.1038/s41598-017-18259-0
- Cani, P. D., Lecourt, E., Dewulf, E. M., Sohet, F. M., Pachikian, B. D., Naslain, D., … Delzenne, N. M. (2009). Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. American Journal of Clinical Nutrition, 90(5), 1236–1243. https://doi.org/10.3945/ajcn.2009.28095
- Cani, P. D., Joly, E., Horsmans, Y., & Delzenne, N. M. (2006). Oligofructose promotes satiety in healthy human: a pilot study. European Journal of Clinical Nutrition, 60(11), 1279–1283. https://doi.org/10.1038/sj.ejcn.1602350
- Chambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-Varghese, S. E. K., … Frost, G. (2015). Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut, 64(11), 1744–1754. https://doi.org/10.1136/gutjnl-2014-307913
- Freeland, K. R., Wilson, C., & Wolever, T. M. S. (2010). Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. British Journal of Nutrition, 103(1), 82–90. https://doi.org/10.1017/S0007114509991462
- Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2014). Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. British Journal of Nutrition, 111(7), 1147–1161. https://doi.org/10.1017/S0007114513003607
- de Jong, J. C. B. C., Lentjes, M. G. W., Pietersma, K. F., Pasman, W. J., Wopereis, S., & Hoevenaars, F. P. M. (2026). Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review. Frontiers in Endocrinology, 17, 1880500. https://doi.org/10.3389/fendo.2026.1880500
- van der Klaauw, A. A., Keogh, J. M., Henning, E., Trowse, V. M., Dhillo, W. S., Ghatei, M. A., & Farooqi, I. S. (2013). High protein intake stimulates postprandial GLP1 and PYY release. Obesity, 21(8), 1602–1607. https://doi.org/10.1002/oby.20154
- Watkins, J. D., Koumanov, F., & Gonzalez, J. T. (2021). Protein- and calcium-mediated GLP-1 secretion: a narrative review. Advances in Nutrition, 12(6), 2540–2552. https://doi.org/10.1093/advances/nmab078
- Wastyk, H. C., Fragiadakis, G. K., Perelman, D., Dahan, D., Merrill, B. D., Yu, F. B., … Sonnenburg, J. L. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137–4153.e14. https://doi.org/10.1016/j.cell.2021.06.019
- Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry, 288(35), 25088–25097. https://doi.org/10.1074/jbc.M113.452516
- Simon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., … Roden, M. (2015). Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: A proof of concept. Diabetes Care, 38(10), 1827–1834. https://doi.org/10.2337/dc14-2690
- Gao, D., Dong, Y., Jia, Z., Bian, C., Zhu, J., Wu, Y., Fang, S., & Gu, S. (2025). Bifidobacterium breve BBr60 improves obesity via the gut microbiota–short-chain fatty acid–IL-27/GLP-1 axis: Evidence from a randomized, double-blind, placebo-controlled trial. Probiotics and Antimicrobial Proteins. Advance online publication. https://doi.org/10.1007/s12602-025-10885-9
- Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., … Tsuchida, T. (2013). Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition, 110(9), 1696–1703. https://doi.org/10.1017/S0007114513001037
- Falony, G., Vlachou, A., Verbrugghe, K., & De Vuyst, L. (2006). Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Applied and Environmental Microbiology, 72(12), 7835–7841. https://doi.org/10.1128/AEM.01296-06
- Fan, Y., & Pedersen, O. (2021). Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology, 19(1), 55–71. https://doi.org/10.1038/s41579-020-0433-9
- Beutler, L. R. (2026). GLP-1 physiology and pharmacology along the gut-brain axis. The Journal of Clinical Investigation, 136(2), e194744. https://doi.org/10.1172/JCI194744
'%3e%3cg%20id='Final-Copy-2_2_'%20transform='translate(1275.000000,%20200.000000)'%3e%3cpath%20class='st0'%20d='M7.4,12.8h6.8l3.1-11.6H7.4C4.2,1.2,1.6,3.8,1.6,7S4.2,12.8,7.4,12.8z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3cg%20id='final---dec.11-2020'%3e%3cg%20id='_x30_208-our-toggle'%20transform='translate(-1275.000000,%20-200.000000)'%3e%3cg%20id='Final-Copy-2'%20transform='translate(1275.000000,%20200.000000)'%3e%3cpath%20class='st1'%20d='M22.6,0H7.4c-3.9,0-7,3.1-7,7s3.1,7,7,7h15.2c3.9,0,7-3.1,7-7S26.4,0,22.6,0z%20M1.6,7c0-3.2,2.6-5.8,5.8-5.8%20h9.9l-3.1,11.6H7.4C4.2,12.8,1.6,10.2,1.6,7z'/%3e%3cpath%20id='x'%20class='st2'%20d='M24.6,4c0.2,0.2,0.2,0.6,0,0.8l0,0L22.5,7l2.2,2.2c0.2,0.2,0.2,0.6,0,0.8c-0.2,0.2-0.6,0.2-0.8,0%20l0,0l-2.2-2.2L19.5,10c-0.2,0.2-0.6,0.2-0.8,0c-0.2-0.2-0.2-0.6,0-0.8l0,0L20.8,7l-2.2-2.2c-0.2-0.2-0.2-0.6,0-0.8%20c0.2-0.2,0.6-0.2,0.8,0l0,0l2.2,2.2L23.8,4C24,3.8,24.4,3.8,24.6,4z'/%3e%3cpath%20id='y'%20class='st3'%20d='M12.7,4.1c0.2,0.2,0.3,0.6,0.1,0.8l0,0L8.6,9.8C8.5,9.9,8.4,10,8.3,10c-0.2,0.1-0.5,0.1-0.7-0.1l0,0%20L5.4,7.7c-0.2-0.2-0.2-0.6,0-0.8c0.2-0.2,0.6-0.2,0.8,0l0,0L8,8.6l3.8-4.5C12,3.9,12.4,3.9,12.7,4.1z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Your Privacy Choices
Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!